FDG PET/CT in colorectal cancer

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jan-Feb;39(1):57-66. doi: 10.1016/j.remn.2019.09.009. Epub 2019 Nov 24.
[Article in English, Spanish]

Abstract

Colorectal cancer is the third most frequent cancer worldwide. Although its incidence is increasing, mainly in those aged under50, mortality has decreased by 50% in the more developed countries, principally due to the adoption of new practices in prevention, diagnosis and treatment. In particular, the various diagnostic imaging modalities allow improved therapeutic decision-making, evaluation of the response and early detection of recurrence. The aim of this paper is to review the available scientific evidence on the value of positron emission tomography with 18F-FDG (18F-FDG PET/CT) in the colorectal cancer, with special emphasis on the indications of the guidelines and recommendations of the main international scientific associations regarding this imaging technique.

Keywords: (18)F-FDG PET/CT; (18)F-FDG PET/TC; CCR; CRC; Colon cancer; Colorectal cancer; Cáncer colorrectal; Cáncer de colon; Cáncer de recto; PET/CT; PET/TC; Rectal cancer.

Publication types

  • Review

MeSH terms

  • Colonic Neoplasms / diagnostic imaging*
  • Colonic Neoplasms / pathology
  • Fluorodeoxyglucose F18*
  • Humans
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / secondary
  • Liver Neoplasms / surgery
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Staging / methods
  • Positron Emission Tomography Computed Tomography*
  • Practice Guidelines as Topic
  • Radiopharmaceuticals*
  • Rectal Neoplasms / diagnostic imaging*
  • Rectal Neoplasms / pathology

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18